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Introduction
As an essential step in conventional protein secretion, coat 
protein complex II (COP II) mediates vesicular transport from 
the ER to the Golgi apparatus in eukaryotes. The GTPase 
SAR1, inner coat proteins SEC23/SEC24, and outer coat pro-
teins SEC13/SEC31 are five cytosolic components of the COP 
II complex, and they are sufficient to generate COP II-coated 
vesicles from synthetic liposomes (Matsuoka et al., 1998; 
Kim et al., 2005). COP II vesicles were observed by EM to be 
∼60–80 nm in diameter, which potentially limits the transport 
of large cargos such as the 300-nm-long procollagen I (PC1) 
rigid rod (Bächinger et al., 1982; Barlowe et al., 1994; Kim 
et al., 2005; Noble et al., 2013). However, human genetic ev-
idence showed that COP II is required to secrete procollagens. 
Mutations in genes that code for the human COP II paralogs 
SEC23A and SEC24D were identified as causing the genetic 
diseases cranio-lenticulo-sutural dysplasia and osteogenesis 
imperfecta and their characteristic collagen deposition de-
fects during development (Boyadjiev et al., 2006; Kim et al., 
2012; Garbes et al., 2015).
The requirement for COP II to secrete PC has been inde-
pendently demonstrated in multiple model systems. Mutation 
of the sec-23 gene in Caenorhabditis elegans disrupts collagen 
secretion and leads to aberrant cuticle, dissociated hypodermal 
cells, and late embryonic lethality (Roberts et al., 2003). In 
Drosophila melanogaster, tissue-specific knockdown of Sar1 
or Sec23 in collagen-secreting fat body cells leads to intracel-
lular accumulation of collagen and cell lethality (Pastor-Pareja 
and Xu, 2011). The zebrafish mutants crusher and bulldog re-
sult from mutations in sec23a and sec24d genes, respectively, 
and their chondrocytes retain procollagen II in the ER. These 
mutants also show defects during craniofacial development, 
with phenotypes reminiscent of human cranio-lenticulo-sutural 
dysplasia (Lang et al., 2006; Sarmah et al., 2010). Sec23A-null 
mice are embryonically lethal, and skin fibroblasts accumulate 
ER-localized collagen I and III (Zhu et al., 2015). Knockdown 
of SEC13 in primary human dermal fibroblasts also selec-
tively blocks PC1 secretion (Townley et al., 2008). Hence, the 
requirement for COP II in the ER exit of PC is evolutionarily 
conserved in metazoans.
The necessary role of COP II in large-cargo secretion is 
further supported by the discovery of a large transmembrane 
protein, TAN GO1 (MIA3), which has been shown to have a 
general role in the secretion of large cargos, including many 
members of the collagen family, laminin, and large lipoprotein 
complexes such as prechylomicrons (Saito et al., 2009; Wilson 
et al., 2011; Petley-Ragan et al., 2016; Santos et al., 2016). The 
luminal Src homology 3 domain of TAN GO1 interacts with 
the PC-specific chaperone HSP47 to recognize a broad range 
of PC isoforms (Saito et al., 2009; Ishikawa et al., 2016). The 
cytosolic side of TAN GO1 was shown to interact with multiple 
COP II components: its proline-rich domain binds to the inner 
COP II coat protein SEC23 directly, and its second coiled-coil 
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domain recruits cTAGE5, a spliced variant of a TAN GO1 iso-
form, which binds SEC12, an initiating factor of COP II assem-
bly (Saito et al., 2009, 2011, 2014; Ma and Goldberg, 2016). 
Therefore, TAN GO1 plays an important role in coordinating 
large-cargo sensing and COP II recruitment, which further sup-
ports the involvement of COP II in large-cargo secretion.
Although the requirement for COP II to export the large-
cargo PC out of the ER is clear, the precise role that COP II plays 
in this process is poorly understood. A conventional model was 
proposed in which COP II concentrates large cargos at ER exit 
sites (ERESs) and orchestrates the packaging of large cargos 
into vesicles and the formation of vesicles with structured coats 
(Fromme and Schekman, 2005). An alternative model suggests 
that COP II functions only to concentrate large cargos and other 
factors required for the ER export at ERESs, and large cargos 
exit the ER in carriers not coated with COP II proteins (Mironov 
et al., 2003; Siddiqi et al., 2003, 2010).
The conventional model is paradoxical unless a cellular 
mechanism exists to increase the size of COP II-coated vesicles. 
The Rape and Schekman laboratories previously reported that 
the E3 ubiquitin ligase, CUL3, and one of its substrate adap-
tors, KLHL12, regulate the size of COP II-coated vesicles and 
collagen I and IV secretion (Jin et al., 2012). Overexpression of 
KLHL12 induces the formation of large COP II structures that 
are decorated with KLHL12. Most of these structures are more 
than 300 nm in diameter and large enough to accommodate 
cargo of the size of PC1. Unfortunately, the coincident local-
ization of PC1 in these large carriers was not clearly elucidated 
in that work. Here, we reexamined these large COP II structures 
and showed that they are bona fide membranous carriers of PC1 
in cells. Moreover, we reconstituted PC1 capture into vesicles 
formed in a cell-free reaction. These carriers were isolated and 
visualized as large COP II-coated vesicles.
Results
Large COP II vesicles colocalize with PC1
The ubiquitin ligase CUL3 and its substrate adaptor KLHL12 
were shown to regulate collagen secretion and the size of COP 
II vesicles, possibly through the monoubiquitylation of the COP 
II protein SEC31A (Jin et al., 2012). To study whether the large 
COP II vesicles observed after overexpression of KLHL12 are 
collagen carriers, we engineered human fibrosarcoma cells 
(KI6) to stably overexpress the human pro-α1(I) collagen and 
inducible KLHL12 under doxycycline-controlled transcrip-
tional activation. KI6 cells synthesized PC1 in contrast to the 
parent cell line as confirmed by an immunofluorescence (IF) 
signal for PC1 (Fig. S1 A) and immunogold-labeled PC1 in the 
ER and large vesicles (Fig. S1 B). KLHL12 overexpression was 
reported to accelerate the ER export of PC1: more cells had se-
creted PC1 after 30 min of ascorbate treatment when KLHL12 
was overexpressed, and no significant difference was observed 
at a later time point (1 h) after ascorbate treatment (Jin et al., 
2012). Consistent with our previous study, we also observed 
accelerated ER-to-Golgi trafficking of PC1 in KI6 cells 20 min 
after ascorbate treatment in cells that had induced KLHL12 
overexpression for 7.5 h (Fig. S1 C; Jin et al., 2012). KI6 cells 
secreted PC1 through the conventional secretory pathway, 
shown by the inhibitory effect of brefeldin A (BFA) on the ex-
port of PC1 into the culture medium (Fig. S1 D). Because TAN 
GO1-knockout mice are defective in collagen I secretion, we 
knocked down TAN GO1 in KI6 cells and observed a decreased 
level of PC1 secretion, as detected by immunoblots of the cul-
ture medium, with a corresponding intracellular accumulation 
of PC1 detected in cell lysates (Fig. S1 E; Wilson et al., 2011).
In our previous study (Jin et al., 2012) using a polyclonal 
antibody (LF-67) raised against synthetic human α1(I) colla-
gen C-telopeptide (Bernstein et al., 1996), we observed partial 
colocalization between PC1 and KLHL12 but could not unam-
biguously document that the large COP II vesicles, generated by 
overexpression of KLHL12, carried PC1. In contrast, with the 
use of two monoclonal antibodies raised against N- or C-pro-
peptides of PC1 (Fig. S2 A; Foellmer et al., 1983), we observed 
clear colocalization of PC1 and KLHL12 in KI6 cells after 7.5 h 
of induction (Figs. 1 A and S2 B). Puncta positive for both PC1 
and KLHL12 also colocalized with SEC31A, a subunit of the 
outer coat of COP II vesicles (Fig. 1 B).
We reasoned that if large COP II vesicles are functional 
secretory transporters of collagen, they should also contain 
HSP47, a collagen-specific chaperone. HSP47 binds to the tri-
ple helical region of PC in the ER and promotes the correct 
folding of trimerized PC (Nagai et al., 2000; Tasab et al., 2000, 
2002; Ishida and Nagata, 2011; Ono et al., 2012; Widmer et 
al., 2012). HSP47 accompanies PC to the ER–Golgi interme-
diate compartment (ERG IC) or cis-Golgi membrane, where it 
dissociates because of a lower pH, after which it is recycled 
back to the ER via its C-terminal RDEL sequence (Satoh et 
al., 1996; Oecal et al., 2016). We found that HSP47 colocal-
ized with the large COP II vesicles as visualized by triple IF 
labeling of HSP47, SEC31A, and KLHL12 in KI6 cells, con-
sistent with a role for the large COP II vesicles as secretory 
carriers of PC1 (Fig. 1 C).
Large COP II vesicles are hollow 
membranous containers
Given that conventional confocal microscopy images revealed 
colocalized diffraction-limited puncta with no discernible mor-
phological details, we sought to resolve these structures using 
stochastic optical reconstruction microscopy (STO RM; Rust et 
al., 2006; Huang et al., 2008), a type of superresolution micros-
copy, and correlative light and electron microscopy (CLEM). 
With 3D STO RM analysis, we observed large, hollow, cage-
like COP II structures that are 300–1,000 nm in diameter, using 
a SEC31A antibody and a secondary antibody conjugated with 
Alexa Fluor 647 fluorophore in KI6 cells induced for the over-
expression of KLHL12 (Fig. 2 A). A virtual z-stack of a single 
structure confirmed the cage-like COP II protein localization 
completely surrounding a cavity in three dimensions. Similar 
analysis was conducted on vesicles immunolabeled with FLAG 
antibody, which targeted the overexpressed KLHL12-FLAG, 
and large hollow cages that were 300–1,000 nm in diameter 
were also observed (Fig. 2 B).
We observed a similar morphological feature by CLEM 
on regions of colocalized endogenous PC1 and SEC31A with-
out KLHL12 overexpression in human osteosarcoma Saos-2 
cells, a cell line that secretes endogenous PC1 (Fig. 2 C; Pautke 
et al., 2004). Correlative serial thin-section EM revealed that 
fluorescent puncta containing colocalized PC1 and SEC31A 
were large, single membrane–bounded compartments and were 
not clusters of small vesicles. These correlated structures were 
spherical to ovoid in shape and 350 nm to 1.7 µm in diame-
ter, decorated with what may be remnants of coat protein. Col-
lectively, the diffraction-limited PC1 and COP II colocalized 
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puncta were resolved by STO RM and CLEM to be large pro-
tein-coated, single membrane–bounded containers.
PC1 is completely encapsulated in large 
COP II-coated membranes
We next sought to dissect the precise localization of PC1 with 
respect to the COP II coat within puncta that showed colo-
calization of the two markers. To achieve this, we performed 
dual- and triple-color 3D STO RM imaging on SEC31A/PC1 
colocalizing puncta from cells with overexpressed and endog-
enous levels of KLHL12. Large COP II cages with hollow cav-
ities were observed in KI6 cells (Fig. 3 Aix), consistent with 
our observation using single-color STO RM (Fig.  2, Aiii and 
Aiv), and PC1 was resolved to be inside of the hollow cavities, 
entirely encapsulated by the COP II cage (Fig. 3, Av–Ax; and 
Video 1). This was also evident in KLHL12/SEC31A/PC1 co-
localizing puncta in Saos-2 cells, where endogenous KLHL12 
and SEC31A was found surrounding the endogenous PC1 
(Fig. 3, Bvi–Bxiii). The appearance of confined labeling of the 
PC1 fiber in relation to the expansive COP II coat may reflect 
a restricted orientation of the fiber within the vesicle or steric 
hindrance of the PC1 monoclonal antibody by the polyclonal 
antibody used to label the coat. In contrast, we did not observe 
PC1 in canonical COP II cages ranging in size from 80 to 100 
nm (Fig.  3, Aii–Aiv). Interestingly, we also observed puncta 
that appeared to have the COP II coat only partially enveloping 
PC1, possibly representing an intermediate in the shedding of 
COP II subunits or a nascent budding event at the ERES (Fig. 3, 
Bii–Bxiii; and Fig. S3, A–C).
PC1-containing giant COP II vesicles 
exhibit movement
The dynamic nature and organization of ER-to-Golgi trans-
port have been visualized previously with the use of fluores-
cent labeling and time-lapse microscopy (Presley et al., 1997; 
Scales et al., 1997; Shima et al., 1999). We sought to understand 
whether the large COP II vesicles were capable of functioning 
as mobile transport carriers independent of the ER. The local-
ization of large COP II vesicles relative to the ERES and ER 
was examined in KI6 cells by dual-color confocal and STO RM 
microscopy using antibodies against SEC31A, SEC16A, a scaf-
folding protein at the ERES, and KDEL, the ER retrieval signal 
Figure 1. Large COP II vesicles colocalize with PC1. (A) PC1 (green) and KLHL12 (red) colocalize in KI6 cells that were treated with doxycycline for 7.5 h 
to induce the expression of KLHL12. Images shown are mean intensity projected views of a z-stack shown for each and merged channel. Red arrowheads 
indicate KLHL12-positive puncta, whereas white arrowheads indicate colocalized puncta. Rightmost panel shows 3D view of KLHL12 puncta obtained 
from the z-stack using the Spot feature in Imaris 8.1.2. An example of colocalizing yellow puncta is indicated by a white arrowhead, and KLHL12-positive 
puncta not colocalizing with PC1 is indicated by a red arrowhead. Total number of KLHL12-positive puncta determined in the z-stack was 27, and 78% of 
these spots were positive for PC1 calculated using CoLoc feature in Imaris 8.1.2. (B) PC1 (green), KLHL12 (magenta), and SEC31A (red) colocalize in KI6 
cells (white arrowhead). DAPI is shown in blue. Half of the total number of KLHL12-positive puncta (n = 14) were positive for PC1 and SEC31A. (C) HSP47 
(green), KLHL12 (red), and SEC31A (magenta) colocalize in KI6 cells (white arrowhead). Of the total number of KLHL12-positive puncta (n = 24) counted 
in 11 cells, 79% were positive for both SEC31 and HSP47. Bars, 10 µm. n = 3.
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at the C terminus of ER resident proteins. Images from both 
approaches showed clear separation of large COP II and ERES 
or ER marker proteins (Fig. 4, A and B). Large puncta positive 
for both SEC31A and SEC16A were also observed by confocal 
microscopy (Fig.  4  A). These coincidently labeled structures 
may represent prebudding complexes of COP II vesicles that re-
mained attached to the ER.
We then visualized the spatiotemporal dynamics of these 
vesicles by imaging YFP-tagged, SEC31A-labeled structures 
with time-lapse microscopy. KLHL12 was induced in KI6 cells 
for 7.5 h, and the cells were treated with ascorbate for 10 min 
to promote the formation of hydroxyproline residues essential 
to the folding and ER exit of PC1 (Stephens and Pepperkok, 
2002). We observed large COP II vesicles exhibiting both 
long-range (>2 µm displacement) and short-range (<2 µm dis-
placement) transport, as previously observed for fluorescently 
tagged small COP II vesicles (Fig.  4, C and D; and Video  2 
Stephens et al., 2000). Long-range transport was not evident 
in cells treated with nocodazole, a microtubule-depolymerizing 
agent, as determined by particle tracking of individual vesi-
cles (Fig. 4, C and D; and Video 3). The long-range mobility 
of large COP II vesicles was observed to be independent of a 
CFP-tagged ER marker (Stephens et al., 2000), which is consis-
tent with our observations in fixed samples (Video 4). To con-
firm that these large mobile COP II vesicles are PC1 carriers, 
we tracked vesicles positive for both YFP-tagged SEC31A and 
CFP-tagged PC1, which also exhibited directional movements 
(Fig. 4 E and Video 5).
COP II is required to package PC1 into 
vesicles that bud from the ER in a cell-
free reaction
To further investigate whether the large-cargo PC1 exits the ER 
within COP II-coated vesicles, we modified a cell-free reaction 
designed to detect the formation of transport vesicles that bud 
from ER membranes in a preparation of permeabilized cells 
(Fig. 5 A; Kim et al., 2005; Merte et al., 2010). Donor ER mem-
brane was prepared from IMR-90 cultured human fibroblasts 
Figure 2. Large COP II vesicles are hollow membranous containers. 3D STO RM images of large SEC31A (A) or KLHL12-FLAG (B) puncta marked as red ar-
rowheads in KI6 cells after 7.5-h induction. Position in depth (z axis) is represented by color according to the color bar in Ai and Bi. (i) Overview of an area 
of the cell imaged by STO RM: SEC31A (A) or FLAG (B). (ii) Magnified maximum xy projection of a large SEC31A (A) or FLAG (B) structure. Virtual cross 
sections of this structure in XZ (iii) and YZ (iv) planes reveal a hollow compartment encapsulated by SEC31A (A) or KLHL12-FLAG (B). (C) CLEM-resolved 
overlapping immunofluorescent PC1 (green; i) and SEC31A (red; ii) puncta as single membrane-bound compartments in cultured Saos-2 cells expressing 
endogenous levels of PC1 and KLHL12. (iii) Representative cell showing colocalizing puncta (n = 36; an example was indicated by white arrowhead) 
was processed for CLEM. Image shows overlay of the merged fluorescent channels (green and red) on a thin-section (70-nm) TEM image (Z1-11). Serial 
sections of 70-nm thicknesses through structure of interest. (iv) Magnified view of lipid bilayer from an area of the single membrane enclosing the organelle. 
n = 2. Bars: (Ai) 1 µm; (Bi) 1 µm; (Aii–Aiv) 200 nm; (Bii–Biv) 200 nm; (Ci–Ciii) 1 µm; (Z1–Z11) 100 nm; (Civ) 10 nm.
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and incubated at 30°C with purified recombinant human COP 
II proteins, cytosol, and nucleotides for 1 h to allow the forma-
tion of transport vesicles. Budded vesicles were isolated by a 
modification of our previous procedures to allow the detection 
of large vesicular carriers. A low centrifugal speed of 7,000 g 
was used to sediment donor membrane from a complete incu-
bation, and the supernatant fraction, which contained budded 
vesicles, was applied to the bottom of an Optiprep step flotation 
gradient. After a high-speed centrifugation step of 250,000 g, 
12 fractions were collected, and their contents were analyzed 
by immunoblotting (Fig. 5 B). Because lipid vesicles are buoy-
ant, they floated to the top of the gradient as shown by the en-
richment of a standard COP II cargo SEC22B in fraction 1. In 
contrast, a soluble cytosolic protein marker, vinculin, was ob-
served at the bottom of the gradient in fractions 7–12. Most 
PC1 signal floated to the top of the gradient and cofractionated 
with SEC22B, indicating that most PC1 in the reaction was as-
sociated with membrane.
To test whether PC1 detected in the floated fractions was 
packaged inside of intact membrane vesicles, we used a col-
lagenase protection assay. When the top floated fraction was 
treated with collagenase at 30°C, most of the PC1 was protected 
from collagenase digestion and became susceptible only when 
detergent (1% Triton X-100) was included to lyse the mem-
brane (Fig.  5  C). Because collagenase digestion was specific 
to collagens, another standard COP II cargo, ERG IC53, was 
used as loading control.
We tested the requirement for COP II in PC1 packaging by 
supplementing the reaction with the inhibitory SAR1B H79G 
GTPase-defective mutant protein in place of wild-type SAR1B 
(Fig. 5 D). Significantly less PC1 was detected in the top floated 
fraction, consistent with the observation that microinjection of 
SAR1 H79G into live cells arrested PC in the ER (Stephens and 
Pepperkok, 2002). As further controls, the cell-free reaction was 
performed in the absence of donor membrane, cytosol, or puri-
fied recombinant COP II proteins, respectively. Immunoblotting 
of the top floated fractions showed that donor membrane, cyto-
sol, purified COP II proteins, and a physiological temperature of 
30°C were required to reconstitute export of PC1 (Fig. 5 D). PC1 
packaging appears to be completely dependent on both cytosolic 
proteins and COP II for packaging; thus, soluble factors in addi-
tion to the COP II coat may be essential to sort PC1 for transport.
PC1 is known to trimerize in the ER, and only the cor-
rectly folded PC1 trimers are chaperoned by HSP47 to exit 
Figure 3. PC1 is completely encapsulated in large COP II-coated vesicles. (A) Two-color 3D STO RM revealed PC1 (cyan) residing inside of large SEC31A 
(magenta) cages in KI6 cells after 7.5 h of induced KLHL12 overexpression. (i) Overview of an area of the cell imaged by STO RM. Small (80- to 100-nm- 
diameter) canonical SEC31A puncta did not colocalize with PC1 (0%, n = 76 puncta, n = 8 experiments). Examples in dashed inset are magnified in ii as 
merged image, in iii as SEC31A, and in iv as PC1. Large SEC31A puncta of diameter larger than 300 nm colocalized with PC1 (76.3%, n = 36 puncta, 
n = 8 experiments). An example in solid inset is magnified in v as merged image, in vi as SEC31A, and in vii as PC1. A virtual cross section in the xz plane 
of the large COP II vesicle is shown in viii as merged image, in ix as SEC31A, and in x as PC1. (B) Triple-color 3D STO RM imaging shows endogenous PC1 
(cyan) encapsulated by endogenous KLHL12 (yellow) and SEC31A (magenta) in Saos-2 cells grown at steady state. xy maximum projection of the overview 
is shown in i and of a magnified vesicle in ii–v. Virtual cross sections in the xz plane are shown in x–xii and yz in vi–ix. Merged three-color channel is shown 
in i, ii, vi, and x; SEC31A in iii, vii, and xi; PC1 in iv, viii, and xii; and KLHL12 in v, ix, and xiii. Bars: (Ai) 1 µm; (Bi) 2 µm; (magnified views) 100 nm.
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Figure 4. Procollagen-carrying vesicles exhibit movement. (A) Confocal microscopy imaging on KI6 cells treated with doxycycline for 7.5 h were labeled 
with SEC16A and SEC31A antibodies. Open arrow in merged image points to a colocalized spot; closed arrow points to a large SEC31A-labeled vesicle 
not colocalizing with SEC16A. (B) Two-color STO RM imaging was performed on KI6 cells induced for KLHL12 overexpression for 7.5 h and then labeled 
with KDEL and SEC31A antibodies. Panels show magnified xy view of a SEC31A (green)-labeled large COP II cage (i); KDEL marker labeling ER (magenta; 
ii); and merged image of the two channels (iii). (C) KI6 cells were transfected with YFP-tagged SEC31A and induced for KLHL12 expression for 7.5 h. (i–iii) 
Time lapse imaging of SEC31A-YFP puncta in cells not treated with nocodazole. Arrowheads indicate a puncta exhibiting long-range transport (>10 µm 
distance). n = 3. (iv–vi) Time-lapse images of SEC31A-YFP puncta after the treatment of 5 µM nocodazole for 30 min. (D) Images shown are the first 
frame of the time-lapse movie overlaid with the trajectories of SEC31A-YFP puncta in the absence (i) and presence (ii) of nocodazole. Trajectories in time 
(0–120 s) represented by color according to the color scale in D. n = 3. (E) Time-lapse imaging of SEC31A-YFP– and PC1-CFP–positive puncta in KI6 cells. 
Arrowheads point to a vesicle that displays a spatial displacement in time. (F) Overview of the cell imaged in E; overlay of merged fluorescent image over 
DIC image shows PC1-CFP in green and SEC31A-YFP in magenta. Bars: (A) 5 µm; (B) 500 nm; (C)10 µm; (D–F) 5 µm.
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the ER en route to the Golgi membrane. Consistent with our 
observation in cells where HSP47 was found to be present on 
the large COP II vesicles, the budding of HSP47 was also ob-
served in the cell-free reaction, which required similar condi-
tions as the budding of PC1 (Figs. 5 D and 1 C). To further 
demonstrate the physiological relevance of our cell-free reac-
tion, we analyzed the content of the floated fractions under a 
nonreducing, denaturing condition, which would preserve the 
interchain disulfide bonds and allow the detection of trimeric 
PC1 (Fig. S2 A). In cell-free reactions supplemented with wild-
type SAR1B, lower-mobility ∼570-kD PC1 (the predicted size 
of PC1 trimer) was detected in the floated fraction under the 
nonreducing, denaturing condition, whereas monomeric ∼190-
kD PC1 was detected under a reducing, denaturing condition 
(Fig.  5  E). Consistent with observations under the reducing, 
denaturing condition, the amount of trimeric PC1 observed in 
the floated fraction was significantly decreased upon incuba-
tion with SAR1B H79G (Fig. 5 E). Thus, we conclude that the 
COP II-dependent packaging of trimeric PC1 and its chaperone 
HSP47 is sustained in our cell-free reaction.
PC1 is exported from the ER in large COP 
II-coated vesicles
To visualize the morphology of vesicular PC1 carriers in the 
floated fraction, we modified the cell-free reaction so that both the 
COP II coat and the large-cargo PC1 were fluorescently labeled. 
For fluorescence visualization of isolated COP II-coated vesicles, 
we added purified Alexa Fluor 647–conjugated SEC23A/24D 
to the reaction mixture (Bacia et al., 2011). For fluorescence 
visualization of PC1, we prepared donor membrane from cells 
that were transiently transfected with a C-terminally GFP-tagged 
construct of the pro-α1(I) chain of human PC1. This construct 
was shown to produce GFP signal that exits the ER in cells incu-
bated in ascorbate-containing medium (Stephens and Pepperkok, 
2002). We confirmed that the GFP tag did not interfere with tri-
merization and ER-to-Golgi transport of PC1-GFP, as GFP signal 
was found at the Golgi apparatus after the addition of ascorbate 
(Fig. S4 A). Moreover, PC1-GFP was packaged in a COP II-de-
pendent manner in the vesicle budding reaction, as detected by 
immunoblotting of GFP in the floated fraction (Fig. S4 B).
Vesicles observed by structured illumination microscopy 
(SIM) displayed PC1 colocalized with large COP II-coated 
structures of ∼400 nm in diameter (Fig. 6 A). With the resolution 
of SIM, the PC1-GFP signal appeared fully within the signal of 
SEC23A/24D (Fig. 6 A and Videos 6 and 7). Smaller COP II 
structures devoid of PC1-GFP, likely to be conventional COP II 
vesicles, were also observed. Not all large COP II structures ob-
served contained the PC1-GFP signal (quantified in Fig. 6, Biii 
and Biv), possibly because only 10–30% of the donor mem-
brane contained GFP signal as a result of low transfection effi-
ciency. It is also possible that PC1 was not the only large cargo 
exiting the ER in large COP II-coated vesicles. Not all PC1-GFP 
observed colocalized with SEC23A/24D: the nonoverlapping 
GFP signal may represent PC1 not enclosed within membranes, 
possibly coinciding with the amount of PC1 that was sensitive 
to collagenase digestion (Fig. 5 C); alternatively, the signal may 
emanate from transport vesicles from which the COP II coat had 
been shed (Fig. 3 B; Fig. S3, A–C; and Fig. S5 A).
Figure 5. COP II is required to export PC1 in 
vesicles that bud from the ER in a cell-free re-
action. (A) Scheme depicting the experimental 
procedure of the cell-free vesicle budding re-
actions. In brief, donor membranes prepared 
from IMR-90 cells were incubated at 30°C 
with cytosol (from HT1080 or HTPC1.1 cells), 
nucleotides (an ATP-regenerating system and 
GTP), and purified recombinant human COP II 
proteins. Vesicles in 7,000-g supernatant frac-
tions from budding reactions were isolated by 
flotation. (B) Fractions (12) were taken from 
the top of an Optiprep gradient after flotation 
and analyzed by immunoblotting. SEC22B 
is found in conventional COP II vesicles and 
serves as a positive control. Vinculin serves 
as a control for cytosolic proteins that do not 
float with vesicles. n = 3. (C) Top floated frac-
tion was treated with or without collagenase 
(0.1 U/µl) in the presence or absence of the 
detergent Triton X-100 (1%) at the indicated 
temperature for 10 min. ERG IC53 is found 
in conventional COP II vesicles and serves as 
loading control. n = 4.  (D) Budding require-
ments of PC1 and HSP47 were assessed 
under different incubation conditions. The top 
fraction after flotation was taken from each 
sample and analyzed by immunoblotting. Ri-
bophorin I is an ER resident protein that serves 
as a negative control. ERG IC53 and SEC22B 
are found in conventional COP II vesicles and 
serve as positive controls. n = 3. (E) To detect 
trimeric PC1, we treated donor membrane or 
floated fractions with nonreducing denatur-
ing sample buffer before gel electrophoresis. 
Donor membrane or floated fractions treated 
with reducing denaturing sample buffers were 
used as controls. n = 2.
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We developed an unbiased flow cytometry approach 
to quantify the relative fluorescence signal associated with 
both conventional and large COP II vesicles. Single parti-
cles (singlets) were gated for their content of fluorescently 
labeled COP II proteins SEC23A/24D and the fluorescent 
lipid dye FM4-64. Particles that satisfied such criteria ac-
counted for ∼0.7% of all singlets detected in the 7,000-g 
supernatant fraction (Fig.  6 Bi). Of these COP II-coated 
vesicles, 9.6% were GFP+, indicating that they carried the 
large cargo PC1-GFP (Fig.  6 Bii). This population of col-
lagen-carrying COP II vesicles exhibited higher side and 
forward light scatter, both of which positively correlate 
with larger particle sizes (Fig. 6, Biii and Biv). The sizes of 
reconstituted COP II-coated vesicles were estimated using 
nanoparticle tracking analysis (NTA), which tracks and an-
alyzes the Brownian motion of each particle (Fig. S5 A; 
Dragovic et al., 2011). COP II-coated vesicles in the range 
of 50–150 nm were ∼17.6× more prevalent than larger 
COP II-coated vesicles in the range of 300–1,000 nm. A 
medium-sized category of 150–300 nm was also observed, 
and it was ∼4.3× less prevalent than the 50- to 150-nm cat-
egory and 4.1× more numerous than the larger vesicles. We 
used thin-section EM to independently confirm the exis-
tence of medium to large coated membrane vesicles, with a 
coat of 10–15 nm (Fig. S5 B).
Recruitment of functional KLHL12 to COP 
II-coated vesicles
To test whether our cell-free COP II vesicle formation reaction 
reconstitutes the cellular behavior of KLHL12, we supplemented 
the reaction with cytosol collected from cells transfected with ei-
ther FLAG-tagged wild-type KLHL12 or a mutant, FG289AA, 
that fails to promote the formation of large COP II vesicles (Jin et 
al., 2012; Fig. 7). Densitometry analyses of immunoblots showed 
6.8× more wild-type KLHL12 in the vesicle floated fraction 
compared with the FG289AA mutant protein (P < 0.0001, paired 
t test, n = 7; Fig. 7, A and B). This result coincided with our pre-
vious observation that KLHL12 FG289AA mutant protein rarely 
colocalized with COP II markers in cells (Jin et al., 2012). The 
relative budding efficiency of PC1 and control COP II cargos was 
also calculated from densitometry analyses of immunoblots, and 
PC1 budding was only marginally stimulated by KLHL12 wild-
type cytosol compared with KLHL12 FG289AA cytosol (P = 
0.0412, paired t test, n = 7; Fig. 7, A and C). Thus, although we 
have reconstituted the association of functional KLHL12 with 
budded vesicles, we were unable to assess the role of this protein 
in the capture of PC1 in our cell-free reaction. There may be 
other rate-limiting components, such as the calcium-binding co-
adaptors PEF1 and ALG2, which may fail to be recruited to the 
site of vesicle budding under the conditions of this incubation 
(McGourty et al., 2016).
Figure 6. PC1 is exported out of the ER in large COP II-
coated vesicles. (A) A representative field of COP II vesicles 
isolated from cell-free vesicle budding reaction visualized 
by SIM. One (indicated by the arrow) contained PC1-GFP 
(green) that was entirely encapsulated by the COP II inner coat 
proteins SEC23A/24D-647 (magenta). The magnified xz and 
yz views are displayed underneath the overview. Approxi-
mately 20 images were collected from each experiment with 
fluorescence controls. n = 3. Bar, 200 nm. (B) Relative size of 
COP II carriers of PC1 compared with regular COP II vesicles 
quantified by flow cytometry; numbers in graphs represent 
the percentage of particles in the respective subpopulation. 
(i) Singlets were plotted for the fluorescence intensities of the 
COP II coat proteins SEC23A/24D-647 (APC-A) and the lipid 
dye FM4-64 (PE-Cy5-A). (ii) Particles positive for both COP 
II and lipid are COP II vesicles and were plotted for the flu-
orescence intensity of PC1-GFP (FITC-A). (iii and iv) The val-
ues of side scatter (SSC-A) versus forward scatter (FSC-A) of 
COP II vesicles that are PC1-GFP negative (iii) or GFP positive 
(iv) are plotted. n = 3.
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Discussion
The function of canonical (60- to 80-nm) COP II vesicles in 
conventional cargo transport is well established: COP II sub-
units concentrate cargo proteins into vesicles that bud from 
the ER and form a structure that dictates the size and contour 
of the bud and completed vesicle (Zanetti et al., 2011). Al-
though a wide range of studies have shown that PC secretion 
is COP II dependent, it has remained unclear whether COP II 
coats the membranes surrounding the large cargo or instead 
plays an indirect role in cargo packaging and transport car-
rier biogenesis. A primary requirement for the transport of 
large cargos would be to overcome the structural constraints 
of a small cage (Noble et al., 2013). KLHL12 was previously 
shown to fulfill this requirement, as overexpressing KLHL12 
induced the formation of large COP II structures (Jin et al., 
2012). Here, we confirmed that these large COP II-coated 
structures appeared hollow, presumably with a space to con-
tain large cargos (Fig. 2, A and B). Similar observations were 
also made in PC1-secreting osteosarcoma cells (Saos-2) with-
out any overexpression of KLHL12 (Figs. 2 C and 3 B). No-
tably, CLEM analysis of these structures in Saos-2 showed a 
COP II-coated single-membrane bilayer envelope surrounding 
a lumenal space filled with PC1 (Fig. 2 C).
Evidence for the contrary model that PC is transported 
out of the ER in non-COP II carriers came from studies of fi-
broblasts released from a PC1 hydroxylation block (Mironov 
et al., 2003). That study reported that PC1 exits from saccu-
lar extensions of the ER that appeared devoid of the COP II 
coat based on IF microscopy and immunogold EM studies. 
Those conclusions were based on the use of a polyclonal an-
tibody, LF-68, that was generated against synthetic peptides 
of a unique sequence selected from the C-telopeptide (non-
triple-helical segment exposed on the C terminus of mature 
collagen after a C-terminal propeptide is cleaved) of human 
α1(I) collagen (Fig. S2 A; Fisher et al., 1995; Bernstein et al., 
1996). Here, using two monoclonal antibodies, QED-42024 
and sp1.d8, directed against C- and N- terminal propeptides 
cleaved from triple-helical PC1, respectively (Fig. S2 A; Foell-
mer et al., 1983), we observed colocalization with large COP 
II structures in KI6 cells where both PC1 and KLHL12 were 
overexpressed (Fig. 1, A–C; and Fig. 3 A), natural collagen I–
secreting svIMR-90 cells that overexpressed KLHL12 (Fig. S2 
C), and natural collagen I–secreting Saos-2 and IMR-90 cells 
where PC1 and KLHL12 are expressed endogenously (Figs. 2 
C, 3 B, and S2 D). We have independently confirmed the results 
of Mironov et al. (2003) using the same polyclonal antibody 
(LF-68) for IF localization (Fig. S2 E). However, we suspect 
that the C-telopeptides are not fully accessible in nondenatured 
PC1 trimers, possibly hindered by the presence of C-terminal 
propeptides, which are cleaved in post-Golgi vesicles or after 
secretion to the extracellular space (Fig. S2 A). Thus this 
polyclonal antibody may have limited utility in IF detection of 
folded PC1 species in early secretory transport vesicles.
Independent of PC1 antibody labeling, the colocaliza-
tion of PC1-CFP and the COP II coat protein SEC31A-YFP 
was also observed in live cells (Fig.  4  E). Moreover, the 
PC-specific chaperone HSP47 also colocalized with KLHL12 
Figure 7. The cellular behavior of KLHL12 is recapit-
ulated in the cell-free reaction. (A) Budding reactions 
were supplemented with 2 µg/µl 293T cytosol con-
taining FLAG-tagged KLHL12 wild-type or FG289AA 
mutant in addition to 2 µg/µl HT1080 cytosol. Cytosol 
(293T cells) that contained GFP and 4 µg/µl HT1080 
cytosol were used as controls with endogenous levels 
of wild-type KLHL12. Top fractions were collected after 
density gradient flotation for immunoblotting analyses. 
A representative experiment of seven independent 
repeats. (B) Relative enrichment of KLHL12 detected 
in the floated fraction. Densitometry quantification of 
FLAG intensities in the floated fraction was divided by 
the corresponding FLAG intensity in the 7,000-g su-
pernatant (input for flotation). Error bars = SD. Paired 
t test. ***, P < 0.0001. n = 7. Mean of wild-type/
mean of FG289AA = 6.80. (C) Relative budding effi-
ciency of PC1, HSP47, ERG IC53, and SEC22B in re-
actions that were supplemented with 293T cytosol that 
contained wild-type KLHL12 or KLHL12 FG289AA. 
Vesicle budding efficiencies were calculated from 
densitometry quantification relative to the control 
lane, where 293T cytosol that contained GFP was 
supplemented. Paired t test was used to analyze the 
difference between wild-type and FG289AA samples 
of each cargo; p-values were 0.0412 for PC1 (*, P < 
0.05), 0.1215 for HSP47, 0.5307 for ERG IC53, and 
0.2993 for SEC22B. Error bars = SD. n = 7.
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and COP II (Fig. 1 C). HSP47 binds to trimerized PC in the ER 
and assists its correct folding by preventing lateral aggrega-
tion (Nagai et al., 2000; Tasab et al., 2000; Ono et al., 2012; 
Widmer et al., 2012). This chaperone traverses the early se-
cretory pathway with PC to ERG IC or cis-Golgi membranes, 
where it is released because of lower pH, before being recy-
cled back to the ER via its C-terminal RDEL sequence (Satoh 
et al., 1996; Oecal et al., 2016). In HSP47-knockout mouse 
embryonic fibroblasts, misfolded PC1 trimers were observed 
to accumulate in the ER and were degraded by autophagy, 
independent of the ERAD-mediated clearance of monomeric 
PC1 aggregates (Ishida et al., 2006). Hence, the observation of 
HSP47 colocalized with large COP II confirms that these large 
COP II structures contain correctly folded triple helical PC1 
and are physiologically relevant.
STO RM and CLEM analyses revealed the ultrastructural 
details of these large COP II structures: collagen became com-
pletely encapsulated in a large COP II coat during vesicle forma-
tion, suggesting that COP II proteins acted directly by forming 
a complete cage around a single membrane bilayer vesicle that 
carried PC1 (Fig. 2). Furthermore, fluorescently labeled large 
COP II vesicles showed microtubule-dependent vectorial move-
ment in live cells (Fig. 4, C–E). To sum up, bona fide large COP II- 
coated single-membrane carriers of PC1 were observed in 
fixed as well as live cells.
In an independent effort to test the role of COP II-coated 
vesicles in the sorting of PC1, we used a cell-free transport 
vesicle budding assay that was previously developed in our 
laboratory to probe the requirements for sorting of conven-
tional COP II cargo proteins (Kim et al., 2005; Merte et al., 
2010). Here, we report an alternative fractionation method to 
detect the ER export of the large-cargo PC1 and its chaperone 
HSP47 (Fig. 5). Using the combination of a buoyant density 
flotation protocol, a collagenase protection assay, and SIM, we 
showed that PC1 exits the ER inside of large membrane vesi-
cles that are coated with COP II proteins (Fig. 5, B and C; and 
Fig. 6 A). Furthermore, the packaging of PC1 requires the ad-
dition of recombinant COP II proteins, as well as other unspec-
ified cytosolic proteins, and depends on the GTPase activity of 
SAR1, the GTP-binding protein that initiates the assembly of 
the COP II coat (Fig. 5 D).
Although we were unable to identify a function for 
KLHL12 in our cell-free reaction, we observed the wild-type 
but not a ubiquitylation-defective mutant form of the protein 
recruited to budded vesicles (Fig. 7). The requirement for cyto-
solic proteins in addition to COP II is consistent with reports in 
the literature of other factors such as Sedlin, Sly1, TFG, ALG2, 
and PEF1 in the export of PC from the ER (Venditti et al., 2012; 
Nogueira et al., 2014; McCaughey et al., 2016; McGourty et al., 
2016). Further resolution of the cytosolic proteins required in 
the cell-free reaction may illuminate those that cooperate with 
KLHL12 to stimulate PC1 packaging.
In summary, we examined the role of COP II during the 
ER export of large-cargo PC1 using a combination of in vivo 
morphological analyses and in vitro reconstitution studies. Our 
results support the conventional model in which COP II partici-
pates directly by forming a large COP II-coated membrane ves-
icle to transport bulky cargo out of the ER. Although the exact 
mechanism by which the size of COP II vesicles is regulated 
awaits further investigation, the cell-free PC1 budding reaction 
described here should aid in such studies.
Materials and methods
Antibodies and plasmids
Commercially available antibodies used for IF and immunoblotting (IB) 
were as follows: mouse anti-PC1 (clone 42024; QED Biosciences; 1:200 
[1 mg/ml stock concentration] for IF); rabbit anti-SEC31A (Bethyl Lab-
oratories; for IF, at 1:200 for confocal and 1:2,000 for STO RM); mouse 
anti-FLAG (Thermo Fisher Scientific; 1:5,000 for IB); goat anti-FLAG 
(Novus Biologicals; for IF at 1:1,000 for confocal and 1:5,000 for 
STO RM); chicken anti-KLHL12 (Novus Biologicals; for IF at 1:200 
for confocal and 1:2,000 for STO RM); mouse anti-KLHL12 (clone 
2G2; Cell Signaling Technology; at 1:1,000 for IB); rabbit anti-calnexin 
(Abcam; at 1:200 for IF); mouse anti-HSP47 (Enzo Life Sciences; at 
1:200 for IF and 1:5,000 for IB); sheep anti-TGN46 (AbD Serotec; at 
1:200 for IF); mouse anti-KDEL (clone 10C3; Enzo Life Sciences; at 
1:200 for IF); mouse anti-vinculin (Abcam; 1:5,000 for IB); and rab-
bit anti-GFP (Torrey Pines Biolabs; at 1:1,000 for IB). Rabbit anti–
ribophorin I, ERG IC53, and SEC22B were made in-house and used at 
1:5,000 for IB. Rabbit anti–PC1 LF-41, -67, and -68 antibodies were a 
gift from L. Fisher (National Institute of Dental and Craniofacial Re-
search, Bethesda, MD; Fisher et al., 1989, 1995; Bernstein et al., 1996). 
LF-67 and LF-68 were raised against the same synthetic peptide of the 
human α1(I) collagen C-telopeptide (aa 1,192–1,218; Bernstein et al., 
1996), and LF-68 was used at 1:1,000 for IF only to repeat previous 
studies (Mironov et al., 2003; Jin et al., 2012). LF-41 was raised against 
a synthetic peptide of the C terminus of the human α1(I) collagen (aa 
1,443–1,464; Fisher et al., 1989) and was used for all anti-PC1 IB at 
1:5,000, but not for IF in this study. The mouse anti-PC1 antibody sp1.
d8 was purified in-house from culture medium of mouse hybridoma cells 
obtained from Developmental Studies Hybridoma Bank at the Univer-
sity of Iowa (Iowa City, IA) using standard procedures and used at 3.75 
ng/µl for IF. Expression constructs for SEC31A-YFP, PC-CFP, PC-GFP, 
and pCFP-ER (encodes a fusion protein consisting of enhanced CFP 
flanked by an N-terminal signal peptide of calreticulin and a C-terminal 
ER retrieval sequence, KDEL) were provided by D. Stephens (Univer-
sity of Bristol, Bristol, England, UK).
Cell culture, transfection, and drug treatments
Human lung fibroblasts IMR-90 and svIMR-90 (IMR-90 immortalized 
with SV-40) were obtained from Coriell Cell Repositories at the National 
Institute on Aging, Coriell Institute for Medical Research. Human os-
teosarcoma Saos-2 and U-2OS and human fibrosarcoma HT-1080 were 
obtained from ATCC. IMR-90, svIMR-90, Saos-2, U-2OS, and HT-1080 
were maintained in DMEM plus 10% FBS (GE Healthcare). The HT-
PC1.1 cell line was generated from HT-1080 as previously described (Jin 
et al., 2012) by stable expression of COL1A1 in a pRMc/CMV plasmid 
(gift from N. Bulleid, University of Glasgow, Glasgow, Scotland, UK) 
and maintained in 0.4 mg/ml G418. The doxycycline-inducible KL-
HL12-3xFLAG stable cell line (KI6) was generated through sequential 
clonal selection of HT-PC1.1 cells that stably integrated pcDNA6/TR 
and KLHL12-3xFLAG in a pcDNA5/FRT/TO vector (Flp-In T-REx 
Core kit; Thermo Fisher Scientific) and were selected in the presence 
of 6 µg/ml blasticidin and 0.2 mg/ml hygromycin, respectively. Cells 
were kept in a 37°C incubator with 5% CO2. Transfection of DNA con-
structs into svIMR-90 and KI6 cells was performed using Lipofectamine 
2000 as detailed in the manual provided by Invitrogen. Transfection 
of DNA constructs to Saos-2, svIMR-90, and U-2OS cells for donor 
membrane preparation and HEK293T cells for cytosol preparation 
was performed using polyethylenimine (PEI) at a DNA/PEI ratio of 
1:3. Ascorbate treatment used 0.25 mM ascorbic acid (Sigma-Aldrich) 
and 1 mM ascorbic-2-phosphate (Sigma-Aldrich) were used for ascorbic 
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treatment. This concentration was in addition to the amount of ascorbic 
acid present in FBS (0.08 mM) as supplied by the manufacturer. Dox-
ycycline (Sigma-Aldrich) was used at 1 µg/ml. BFA (Sigma-Aldrich) 
was used at 10 µg/ml. Nocodazole (Sigma-Aldrich) was used at 5 µM.
Immunofluorescence
Cells growing on poly-l-lysine–coated glass coverslips were fixed in 
4% PFA for 20 min at RT or 30 min at 4°C, washed five times with 
PBS, and incubated with permeabilization buffer (PBS containing 
0.1% Triton X-100 and 0.2 M glycine) at RT for 15 min. Cells were 
incubated with blocking buffer (0.5% BSA in PBS) for 30 min at RT 
followed by incubation for 1 h each at RT with primary antibody and 
then secondary antibody. Antibody incubations were followed by five 
washes with PBS. Coverslips were mounted in ProLong-Gold antifade 
mountant with DAPI (Thermo Fisher Scientific) overnight, before 
imaging. Images were acquired using Zen 2010 Software on an LSM 
710 confocal microscope system (ZEI SS). The objectives used were 
Plan-Apochromat 100×, 1.4 NA, and Plan-Apochromat 100×, 1.4 NA. 
The excitation lines and laser power used were 488 (4%), 543 (6%), 
405 (2%), and 633 (6%). Colocalization analysis was performed using 
the spots detection algorithm in the image-processing module Imaris 
8.1.2. In brief, a total number of KLHL12 labeled puncta in the z-stack 
was obtained, and the percentage of puncta positive for both KLHL12 
and PC1 was calculated.
Immunoblotting
Standard immunoblotting procedures were followed. In brief, sam-
ples were heated at 65°C for 10 min, resolved on 4–20% polyacryl-
amide gels (15-well, Invitrogen; 26-well, Bio-Rad Laboratories), and 
transferred to PVDF (EMD Millipore) at constant 0.15A for 16 h. The 
PVDF membrane was incubated with antibodies (primary for 2.5 h and 
secondary for 1 h at RT), and bound antibodies were visualized by the 
enhanced chemiluminescence method (Thermo Fisher Scientific) on 
a ChemiDoc Imaging System (Bio-Rad Laboratories) with ImageLab 
software v4.0 (Bio-Rad Laboratories).
Immunoelectron microscopy
KI6 cells were grown on 35-mm glass-bottom dishes (MatTek Corp.) 
and fixed with 4% PFA and 0.05% glutaraldehyde for 30 min. Cells 
were washed with PBS and incubated with blocking buffer (0.5% BSA 
and 0.02% saponin in PBS) at RT for 20 min. Primary antibody label-
ing was done at RT for 1 h followed by overnight incubation at 4°C in 
the presence of saponin. Secondary antibody labeling (1:50 dilution of 
1.4 nm Nanogold-conjugated goat anti-mouse Fab′ fragment; Nano-
probes) was done at RT for 2  h.  The Nanogold particles were gold 
enhanced in the dark for 5–7 min per the manufacturer’s instructions 
using GoldEnhance (Nanoprobes). Cells were postfixed with 1% os-
mium tetroxide and processed for thin-section EM.
Correlative light and electron microscopy
Saos-2 cells were grown on gridded 35-mm glass-bottom dishes (Mat-
Tek Corp.) and fixed with PFA (4% in culture medium; Electron Mi-
croscopy Sciences). The cells were processed for IF as described earlier 
with the exception that 0.02% saponin was used as the permeabilizing 
agent, a concentration well below the established protocol, which typ-
ically uses 0.1% saponin (Mironov et al., 2005). The cells (in PBS) 
displaying colocalized PC1/SEC31A spots were imaged at RT on a 
Zeiss 710 confocal microscope using a C-Plan Apochromat 63×/1.2 
W objective followed by marking the alphanumeric location using a 
5×/0.12-NA objective. A z-stack series of the cell of interest was also 
collected using Zen 2010 software. The cells were then fixed for 30 min 
in 0.1 M cacodylate buffer, pH 7.2, containing 2% glutaraldehyde and 
washed with 0.1 M sodium cacodylate buffer before postfixation with 
1% osmium tetroxide for 30 min on ice. This was followed by stain-
ing with 1% aqueous uranyl acetate for 30 min at RT. For dehydration 
with progressive lowering of temperature, each incubation period was 
10 min, with exposure to 35% ethanol at 4°C, 50% ethanol and 70% 
ethanol at −20°C, and 95% and 100% ethanol at −35°C. Cells were 
restored to RT in 100% ethanol before embedding in an epon resin. 
The cell of interest was identified by the grid location on the resin and 
thin (70- to 100-nm) serial sections were collected on Formvar-coated 
200-mesh copper grids and poststained with 2% aqueous uranyl acetate 
and 2% tannic acid. The sections were imaged at 120 kV using a Tecnai 
12 Transmission Electron Microscope (FEI). Regions of interest were 
identified manually by correlating the z-slices of the confocal stack 
with the serial sections and laying the fluorescent image over the TEM 
image by marking down prominent cell landmarks such as the nuclear 
boundary, vacuoles, and mitochondria. The overlay was confirmed 
using the Icy software package (de Chaumont et al., 2012).
STO RM imaging
Immunofluorescently labeled cell samples were mounted on glass 
slides with a standard STO RM imaging buffer consisting of 5% (wt/
vol) glucose, 100 mM cysteamine, 0.8 mg/ml glucose oxidase, and 40 
µg/ml catalase in Tris-HCL, pH 7.5 (Rust et al., 2006; Huang et al., 
2008), and sealed using Cytoseal 60 (Thermo Fisher Scientific). STO 
RM imaging was performed on a home-built setup based on a mod-
ified Eclipse Ti-U inverted fluorescence microscope (Nikon) using a 
Nikon CFI Plan Apo λ 100× oil-immersion objective (NA 1.45). Dye 
molecules were photo switched to the dark state and imaged using ei-
ther 647- or 560-nm lasers (MPB Communications); the lasers were 
passed through an acousto-optic tunable filter and introduced through 
an optical fiber into the back focal plane of the microscope and onto the 
sample at intensities of ∼2 kW/cm. A translation stage was used to shift 
the laser beams toward the edge of the objective so that light reached 
the sample at incident angles slightly smaller than the critical angle of 
the glass-water interface. A 405-nm laser was used concurrently with 
either the 647- or 560-nm lasers to reactivate fluorophores into the 
emitting state. The power of the 405-nm laser (typical range 0–1 W/cm) 
was adjusted during image acquisition so that at any given instant, only 
a small, optically resolvable fraction of fluorophore in the sample was 
in the emitting state. For 3D STO RM imaging, a cylindrical lens was 
inserted into the imaging path so that images of single molecules were 
elongated in opposite directions for molecules on the proximal and 
distal sides of the focal plane (Huang et al., 2008). The raw STO RM 
data were analyzed according to previously described methods (Rust 
et al., 2006; Huang et al., 2008). Data were collected at a frame rate of 
110 Hz using an iXon Ultra 897 EM-CCD camera (Andor), for a total 
of ∼80,000 frames per image. Three-color imaging was performed on 
targets labeled by Alexa Fluor 647, CF680, and CF568 via sequential 
imaging with 647- and 560-nm excitation. With 647-nm excitation, a 
ratiometric detection scheme (Bossi et al., 2008; Testa et al., 2010) was 
first used to concurrently collect the emission of single Alexa Fluor 
647 and CF680 molecules. Emission of single molecules was split into 
two light paths (channels) using a long-pass dichroic mirror (T685lpxr; 
Chroma), each of which was projected onto one-half of an iXon Ultra 
897 EM-CCD camera. We performed fluorophore assignment by lo-
calizing and recording the intensity of each single molecule in the two 
channels. Excitation at 560 nm was subsequently used to image CF568 
through the reflected light path of the dichroic mirror.
Live-cell imaging, particle tracking, and image analysis
KI6 cells were transfected with plasmids encoding SEC31A-YFP and 
PC1-CFP for a period of 9 h and induced for 7.5 h with doxycycline 
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within that time period to induce the overexpression of KLHL12. The 
cells were imaged using a temperature-controlled LSM 710 Axio Ob-
server microscope (ZEI SS; Plan-Apochromat 63×, 1.4 NA oil DIC 
M27; standard ZEI SS PMT detectors) at 37°C in prewarmed phenol 
red–free culture medium. Main beam splitters were MBS-405 and 
MBS-458/514. Emission wavelengths collected were at 454–516 nm 
and 519–621 nm. Cells were imaged every 5  s for 2 min starting at 
the end of 10-min treatment with ascorbate and recorded using Zen 
2010 software. For experiments requiring nocodazole treatment, the 
drug was added for 30 min before imaging. Particle detection and 
tracking were performed using Imaris v8.1 (Bitplane USA). Images 
were first subjected to background subtraction, and the Spots module 
was used to automatically detect point-like particles with spot diame-
ter of 200 nm. Appropriate threshold values were confirmed. Object 
tracing through sequential time frames was done using an autoregres-
sive motion particle-tracking algorithm. A maximum search distance 
of 5 µm was defined. A gap-closing algorithm was also implemented 
to link track segment ends to track segment starts. Track outputs were 
then visually inspected.
Vesicle budding reaction
Vesicle budding reactions were performed as previously described in 
Kim et al. (2005) with the following modifications. Donor ER mem-
brane was prepared fresh for each reaction by permeabilizing young 
(under PDL 37.5) IMR-90 cells (95% confluent in 3 × 10-cm dishes) 
treated with 20 µg/ml digitonin (5 min on ice) in B88 (20 mM Hepes, 
pH 7.2, 250 mM sorbitol, 150 mM potassium acetate, and 5 mM mag-
nesium acetate) and washed with 0.5  M LiCl in B88 then B88 and 
resuspended in 200 µl B88-0 (20 mM Hepes, pH 7.2, 250 mM sorbi-
tol, and 150 mM potassium acetate) to a final concentration of OD600 
2–6. Each 100-µl reaction contained ATP regeneration system (1 mM 
ATP, 40 mM creatine phosphate, and 0.2 mg/ml creatine phosphoki-
nase), 3 mM GTP, purified human COP II proteins (2 µg SAR1B, 1 µg 
SEC23A/24D, and 1 µg SEC13/31A), cytosol (2 µg/µl unless otherwise 
stated, see “Cytosol preparation” for details), and a final concentration 
of 5 OD600/ml donor ER membrane in B88-0.  Vesicles generated in 
vitro were isolated from the reaction mixture in two steps. First, donor 
membranes were sedimented by centrifuging twice at 7,000 g at 4°C 
for 5 min each in a swinging bucket rotor (S-24-11-AT; Eppendorf). 
Then, 85  µl of the supernatant was mixed with 50  µl of 60% Opti-
Prep (Sigma-Aldrich) gently until homogeneous, placed at the bottom 
of a 7 × 20-mm tube (Beckman Coulter), and overlaid with 100 µl of 
18% and 10  µl of 0% OptiPrep in B88. The OptiPrep gradient was 
centrifuged at 250,000  g for 90 min at 4°C (Beckman TLS-55 with 
adaptors for 7 × 20-mm tubes) with slow acceleration and decelera-
tion, after which 20-µl fractions were collected from the top and mixed 
with sample buffer for immunoblotting analysis. When a vesicle bud-
ding reaction was analyzed by SIM or flow cytometry, the donor ER 
membrane was prepared from cells (2 × 10-cm, 80% confluent Saos-
2, 40% confluent U-2OS, or 60% confluent svIMR-90 at the time of 
transfection) transiently transfected with 7.5 µg COL1A1-GFP per 
10-cm plate using PEI (Sigma-Aldrich) for 72 h when cells were 100% 
confluent. The reaction was supplemented with fluorescently labeled 
SEC23A/24D. Fluorescent SEC23A/24D was produced as previously 
described in Bacia et al. (2011) using Alexa Fluor 647 C2 maleimide 
(Thermo Fisher Scientific). An extended version of the protocol for the 
cell-free reconstitution of COPII-coated procollagen I carriers can be 
found in Bio-protocol (https://doi.org/10.21769/BioProtoc.2450).
Protein purification
Human SAR1 proteins were overexpressed in Escherichia coli and 
purified as cleaved GST-fusions, as described for hamster Sar1 
purifications in Kim et al. (2005). In brief, a bacterial lysate was first 
centrifuged at 43,000 g for 15 min, then the supernatant fraction was 
further centrifuged at 185,000 g for 1 h. The supernatant was incubated 
with prewashed glutathione agarose (1  ml slurry/l bacteria; Thermo 
Fisher Scientific) for 1 h at 4°C. Agarose was washed with wash buf-
fer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.1% Tween, 5 mM MgCl2, 
and 100 µM GDP), and SAR1 was eluted by cleaving with 20 U/ml 
thrombin (Roche) in TCB (50 mM Tris, pH 8, 250 mM KoAc, 5 mM 
CaCl2, 5 mM MgCl2, and 100 µM GDP). Human SEC13/31A and SE-
C23A/24D were purified from lysates of baculovirus-infected insect 
cells, as described previously (Kim et al., 2005). In brief, insect cell 
lysates were centrifuged at 185,000  g for 1  h, and 30% ammonium 
sulfate was added to the supernatant fraction at 4°C. The precipitant 
was collected by centrifugation at 30,000 g for 30 min and solubilized 
in no-salt buffer (20 mM Hepes, pH 8, 10% glycerol, 250 mM sorbitol, 
0.1 mM EGTA, 5 mM β-mercaptoethanol, and 10 mM imidazole). The 
solubilized 30% ammonium sulfate precipitant was cleared at 30,000 g 
for 20 min, and the supernatant was incubated with prewashed Ni-NTA 
resin (1.25 ml slurry/l insect cells; Thermo Fisher Scientific) for 1 h 
at 4°C. Ni-NTA was washed with 20 mM Hepes, pH 8, 10% glycerol, 
250 mm sorbitol, 500 mM KoAc, 0.1 mM EGTA, 5 mM β-mercap-
toethanol, and 50 mM imidazole and eluted with 250 mM imidazole. 
Ni-NTA–eluted protein was further purified using an anion exchange 
column (MonoQ) on an AKTA FPLC system (GE Healthcare).
Cytosol preparation
Plates (20 × 15 cm) of HT-1080 or HT-PC1.1 cells were cultured to 
confluence, washed with PBS, and gently scraped in B88 with protease 
inhibitors (Roche). Plates (5 × 15 cm) of HEK293T cells were tran-
siently transfected with 18 µg of empty pEGFP_n1 plasmid, wild-type, 
or mutant KLHL12-3xFLAG in a pcDNA5/FRT/TO vector per 15-cm 
plate, and cells were collected 24 h after transfection by pipetting with 
PBS after gently washing with PBS. The collected cells were perme-
abilized with gentle rocking for 30 min in 80 µg/ml digitonin in 5 ml 
B88 per five 15-cm plates with protease inhibitors at the concentra-
tion suggested by manufacturer (Roche) at 4°C.  The cell lysate was 
collected as a supernatant fraction after centrifugation at 300 g for 5 
min. Digitonin was removed from the cell lysate by incubating with 
washed Bio-Beads SM2 (dry weight of 1 g beads per five 15-cm dishes; 
Bio-Rad Laboratories) at 4°C overnight. Bio-Beads were removed by 
centrifugation at 300 g for 5 min. The supernatant fraction was further 
centrifuged at 160,000 g for 30 min, and the clarified supernatant was 
collected and concentrated with an Amicon Ultra-3k (EMD Millipore) 
filter to 40–80 mg/ml. Small aliquots were frozen in liquid nitrogen and 
stored at −80°C for future use in vesicle budding reactions.
Collagenase protection assay
Top fractions collected after Optiprep gradient flotation were pooled 
and redistributed to each reaction to ensure that all samples had the 
equal starting material. Samples were mixed with or without 0.1 U/µl 
collagenase (Sigma-Aldrich) in the presence or absence of 1% Triton 
X-100 (Sigma-Aldrich) and incubated at 0°C or 30°C for 10 min.
Structured illumination microscopy Imaging
Donor ER membrane isolated from cells that expressed PC-GFP was 
incubated with purified Alexa Fluor 647–conjugated SEC23A/24D and 
other components, as specified, and budded vesicles were isolated from 
the top of the flotation gradient as described in “Vesicle budding re-
action.” Budded vesicles were mounted in Prolong Diamond (Invitro-
gen) under no. 1.5H coverslips (ZEI SS) and set for at least 5 d before 
imaging to eliminate drift. z-stacks of 1–2 µm were collected in three 
rotations and five phases using the 100×/1.46 objective on Elyra PS.1 
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superresolution microscope (ZEI SS) with less than 2% laser power 
and less than 400-ms exposure in all channels, which was determined 
using no fluorescence and single-channel fluorescence controls. Im-
ages were reconstructed and channels were aligned using Zen Black 
software (ZEI SS). Images and videos of 3D iso-surface renderings of 
each channel were done using Imaris v8.1 (Bitplane USA). Image ac-
quisition, processing, and 3D rendering were done using equipment 
and software in the CNR Biological Imaging Facility at the University 
of California, Berkeley.
Flow cytometry
Vesicle budding reactions were scaled up 6× for flow cytometry anal-
yses. After a 7,000-g, 10-min centrifugation of a 600-µl cell-free re-
action, 540 µl supernatant was collected from the top. The lipid dye 
FM4-64 (Thermo Fisher Scientific) was added to the supernatant at 
5 µg/ml immediately before the flow cytometry analyses. 100,000 par-
ticles were collected for each sample. FSC-A and FSC-H were used to 
gate for single particles (singlets), which were used for further analy-
sis. Gating of each fluorescent channel was determined by comparing 
a control sample without any fluorescent labeling and a control that 
was labeled in a single channel. Data were collected on a BD LSR 
Fortessa (BD) and analyzed by FlowJo software. Instrument and soft-
ware were provided by the LKS flow core facility at the University 
of California, Berkeley.
Nanoparticle tracking analysis
Size of vesicles budded in vitro were estimated using the NanoSight 
NS300 instrument equipped with a 405-nm laser (Malvern Instru-
ments). Qdot525-positive particles were analyzed with a 500-nm filter 
(fluorescent mode); nonfluorescent particles were analyzed in the scat-
ter mode without a filter. Silica 100-nm microspheres (Polysciences) 
were analyzed to check instrument performance and determine the vis-
cosity coefficient of B88. Vesicles were collected from the top 20 µl 
of the flotation gradient as described in the Vesicle budding reaction 
section and diluted 40× with 780 µl filtered B88 (0.02 µm; Whatman). 
To label COP II with the fluorescent Qdot525, the 7,000-g supernatant 
fraction was incubated with mouse anti-SEC31A primary antibody 
(1:100; BD) and donkey anti–mouse IgG secondary antibody Qdot525 
conjugate (1:100; Thermo Fisher Scientific) for 1 h at RT. As a labeling 
control, primary antibody was omitted. The labeled supernatants were 
used as inputs for flotation (see details in Vesicle budding reaction), and 
2× top 20 µl of floated fractions was collected from duplicates, to dou-
ble the labeling material, and diluted 20× with 760 µl filtered B88 (0.02 
µm; Whatman). The samples were automatically introduced into the 
sample chamber at a constant flow rate of 50 (arbitrary manufacturer 
unit, ∼10 µl/min) during five repeats of 60-s captures at camera level 13 
in scatter mode and level 15 in fluorescent mode with Nanosight NTA 
3.1 software (Malvern Instruments). Each sample was measured at two 
different positions of the syringe introduction to minimize the hetero-
geneous flow of vesicles. The particle size was estimated with detec-
tion threshold 3 for fluorescent mode and 5 for scatter mode using the 
Nanosight NTA 3.1 software, after which “experiment summary” and 
“particle data” were exported. Particle numbers in each size category 
was calculated from the particle data, in which “true” particles with 
track length >3 were pooled, binned, and counted with Excel (Micro-
soft). GraphPad Prism 7 was used for graphing and statistical analyses.
Electron microscopy of budded vesicles
For morphological analysis of the budded vesicles, the top 80 µl of a 
supernatant fraction after the 7,000-g, 10-min spin of a 100-µl reaction 
was fixed with 2% PFA and 0.2% glutaraldehyde in B88 buffer for 15 
min at 4°C and centrifuged at 25,000 g (Beckman TLS-55 with adaptors 
for 11 × 34-mm tubes) for 30 min with slow acceleration and decelera-
tion on to a 0.5-ml agarose bed (2% low melting point; Sigma-Aldrich). 
This centrifugation speed was optimized to collect large COP II-coated 
vesicles. After three washes in B88 buffer, the pellet was embedded in 
12% gelatin, cut in small blocks, and infiltrated with 2.3 M sucrose in 
0.1 M phosphate buffer at pH 7.4 overnight at 4°C. The blocks were 
mounted on pins and stored frozen in liquid nitrogen. Ultrathin cryo-
sections were collected on Formvar and carbon-coated nickel grids, 
poststained with 2% uranyl acetate, and imaged at 120 kV using a Tec-
nai 12 Transmission Electron Microscope.
Online supplemental material
Fig. S1 shows the validity of using the KI6 cell line stably transfected 
with PC1 and doxycycline-inducible KLHL12 for functional assays. 
Fig. S2 shows IF data comparing two monoclonal antibodies (sp1.d8 
and QED-42024) with polyclonal antibody LF-68. Fig. S3 shows triple 
IF (PC1/SEC31A/KLHL12) labeling of partially coated large COP II 
vesicles by STO RM microscopy. Fig. S4 shows that overexpressed 
PC1-GFP acts similarly to endogenous PC1: PC1-GFP was observed in 
the Golgi apparatus after an ascorbate chase in cells and in the floated 
vesicle fractions generated by the in vitro budding assay in a COP II-de-
pendent manner. Fig. S5 shows size distribution of the vesicles gener-
ated in the budding assay using NTA and EM. Video 1 shows z-sections 
through a PC1/SEC31A-immunolabeled vesicle by STO RM analysis. 
Video 2 shows movement of YFP-tagged SEC31A vesicles by live-cell 
imaging. Video 3 shows live-cell imaging of the YFP-tagged SEC31A 
vesicles in the presence of 5  µM nocodazole. Video  4 shows move-
ment of YFP-tagged SEC31A vesicles separated from ER marked by 
a CFP-tagged ER marker. Video 5 shows movement of SEC31A-YFP 
and PC1-CFP tagged vesicles. Videos 6 and 7 show more examples of 
the reconstituted COP II-coated PC-1 carriers and regular COP II-coated 
vesicles visualized by SIM.
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